CGT

208개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved208 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTCurated CoreFDAstaleFerring PharmaceuticalsApproved

nadofaragene firadenovec (Adstiladrin, rAd-IFNα/Syn3, nadofaragene firadenovec-vncg)

High-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) · IFNα2b (adenoviral)

#IFN2badenoviral#CGT#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 10Status Approved
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Anti-B Cell Maturation Antigen (BCMA, Anti-B Cell Maturation Antigen, Anti-B Cell Maturation Antigen (BCMA) chimeric antigen receptors (CARs) T cells)

Myeloma-Multiple; Myeloma, Plasma-Cell · BCMA

#BCMA#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 131Status Active
CGTLimited DatastaleImmunityBio, Inc.Phase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+3
Trials 59Status Discontinued
CGTLimited DatastaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTLimited DatastaleImmunityBio, Inc.Phase 2

IL-15 Superagonist (N-803, N-803 (IL-15 Superagonist))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 57Status Discontinued
CGTLimited DatastaleNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

Anti-cluster of differentiation 19 (CD19, Anti-cluster of differentiation 19, Anti-cluster of differentiation 19 (CD19)-CAR PBL)

Primary Mediastinal B-cell Lymphoma; Diffuse, Large B-cell Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 55Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Anti-cluster of differentiation 19 (CD19, Anti-cluster of differentiation 19, Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptor (CAR) T cells)

Lymphoma, B-Cell; Lymphoma, Non-hodgkins · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 55Status Active
CGTLimited DatastaleTakara Bio Inc.Phase 1

TS-1 (TS-1)

Pancreatic Cancer Stage III; Pancreatic Cancer Stage IV · Pancreatic Cancer Stage III

#PancreaticCancerStageIII#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 55Status Recruiting
CGTLimited DatastaleShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 54Status Active
CGTLimited DatastaleOno Pharmaceutical Co., Ltd.Phase 3

tegafur-gimeracil-oteracil potassium (tegafur-gimeracil-oteracil potassium)

Gastric Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
CGTLimited DatastaleAlaunos TherapeuticsPreclinical

autologous activated T lymphocyte (autologous activated T lymphocyte)

Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer · Relapsed or Advanced Gastric Adenocarcin

#RelapsedorAdvancedGastricAdenoca#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 51Status Active
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleInnovative Cellular Therapeutic…Phase 2

CART-19 (CART-19)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 44Status Active
CGTLimited DatastaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 40Status Recruiting
CGTLimited DatastaleViroMissile, Inc.Phase 1

oncolytic vaccinia virus (IDOV-Immune, IDOV-Immune (oncolytic vaccinia virus))

Colorectal Cancer; Pancreatic Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 40Status Recruiting
CGTLimited DatastaleOncolytics BiotechPhase 2

Pelareorep (Pelareorep)

Breast Cancer · Breast Cancer Metastatic

#BreastCancerMetastatic#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 35Status Recruiting
CGTLimited DatastaleKecellitics Biotech Company LtdPreclinical

anti-CD19 CAR (anti-CD19 CAR)

Pediatric Cancers; Hematologic Malignancies · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 33Status Active
CGTLimited DatastaleOriCell Therapeutics Co., Ltd.Phase 1

CAR-T infusion (CAR-T infusion)

Refractory Metastatic Colorectal Cancer · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 32Status Active

1 / 11 pages

← PreviousNext →